Loading organizations...
§ Venture Capital
Magpie MedTech Ventures operates as a specialized fund dedicated to furnishing pre-seed capital and domain expertise to nascent medical device and digital health startups. The firm distinguishes itself through its robust capabilities in regulated venture creation, leveraging deep industry networks and a strategic partnership with the New England Medical Innovation Center (NEMIC). This integrated approach provides critical support beyond mere financial investment, focusing on expert guidance throughout the early development phases of MedTech innovations.
The fund was established in 2020, with Aidan Petrie, a founding partner of NEMIC, among the key individuals instrumental in its formation. The foundational insight behind Magpie MedTech Ventures stems from the collective experience of its principals, who possess extensive backgrounds as physicians with deep clinical expertise, corporate executives, serial entrepreneurs, and investors. This cadre recognized a pressing need for tailored capital and comprehensive operational guidance for early-stage ventures in the rapidly evolving medical technology landscape.
Magpie MedTech Ventures primarily serves early-stage medical device and digital health startups seeking both financial backing and strategic mentorship. The firm’s overarching mission is to foster high-impact MedTech by imparting valuable industry insights, practical knowledge, and crucial connections. It endeavors to ensure the success of its portfolio companies through task-based coaching and a forward-looking vision aimed at commercialization and market adoption.
Magpie Neurosurgical Innovation Venture Fund has 1 tracked investment across 1 company. The latest tracked deal is $6.0M Other Equity in Lenoss Medical in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 17, 2026 | Lenoss Medical | $6.0M Other Equity | — | James Goulka, Beacon Angels, Highpoint Ventures, Thorne Sparkman, Xcellerant Ventures |